CLINICAL-SIGNIFICANCE OF CORONARY-ARTERY DISEASE IN HYPERTROPHIC CARDIOMYOPATHY

被引:18
作者
LAZZERONI, E [1 ]
ROLLI, A [1 ]
AURIER, E [1 ]
BOTTI, G [1 ]
机构
[1] OSPED REG PARMA, DIV CARDIOL, PARMA, ITALY
关键词
D O I
10.1016/0002-9149(92)91197-C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of coronary artery disease (CAD) in hypertrophic cardiomyopathy (HC) has not been thoroughly clarified. To assess the clinical and prognostic significance of these 2 coexistent diseases, 96 patients with HC (62 men, mean age 45 years) who underwent coronary arteriography and 2-dimensional echocardiography were studied. Significant stenosis (>70%) of 1 or more coronary arteries was detected in 11 patients, all aged >45 years. This group, compared with the other group without significant CAD (n = 85), was characterized by an older age (59 +/- 7 vs 42 +/- 15 years; p <0.05), a greater prevalence of previous myocardial infarction (24 vs 0%; p <0.001), complex ventricular arrhythmias (100 vs 50%; p <0.05), non-obstructive forms (92 vs 46%; p <0.05), dilated (45 vs 7%; p <0.02) and hypocontractile left ventricle (36 vs 6%; p <0.01) and higher mortality (36 vs 8%; p <0.05) during a mean follow-up of 3.6 years. It is concluded that CAD associated with HC is a complex clinic-al syndrome, difficult to diagnose clinically, that can reliably be. recognized by coronary angiography. CAD seems to play an important role in modifying the pathophysiology, the natural history and the prognosis of HC.
引用
收藏
页码:499 / 501
页数:3
相关论文
共 26 条
[1]   CORONARY VASODILATION IS IMPAIRED IN BOTH HYPERTROPHIED AND NONHYPERTROPHIED MYOCARDIUM OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - A STUDY WITH N-13 AMMONIA AND POSITRON EMISSION TOMOGRAPHY [J].
CAMICI, P ;
CHIRIATTI, G ;
LORENZONI, R ;
BELLINA, RC ;
GISTRI, R ;
ITALIANI, G ;
PARODI, O ;
SALVADORI, PA ;
NISTA, N ;
PAPI, L ;
LABBATE, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (04) :879-886
[2]   DIFFERENCES IN CORONARY FLOW AND MYOCARDIAL-METABOLISM AT REST AND DURING PACING BETWEEN PATIENTS WITH OBSTRUCTIVE AND PATIENTS WITH NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY [J].
CANNON, RO ;
SCHENKE, WH ;
MARON, BJ ;
TRACY, CM ;
LEON, MB ;
BRUSH, JE ;
ROSING, DR ;
EPSTEIN, SE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (01) :53-62
[3]   MYOCARDIAL ISCHEMIA IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - CONTRIBUTION OF INADEQUATE VASODILATOR RESERVE AND ELEVATED LEFT-VENTRICULAR FILLING PRESSURES [J].
CANNON, RO ;
ROSING, DR ;
MARON, BJ ;
LEON, MB ;
BONOW, RO ;
WATSON, RM ;
EPSTEIN, SE .
CIRCULATION, 1985, 71 (02) :234-243
[4]   RELATION BETWEEN MARKED CHANGES IN LEFT-VENTRICULAR OUTFLOW TRACT GRADIENT AND DISEASE PROGRESSION IN HYPERTROPHIC CARDIOMYOPATHY [J].
CIRO, E ;
MARON, BJ ;
BONOW, RO ;
CANNON, RO ;
EPSTEIN, SE .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) :1103-1109
[5]   CORONARY-ARTERY DISEASE IN HYPERTROPHIC CARDIOMYOPATHY [J].
COKKINOS, DV ;
KRAJCER, Z ;
LEACHMAN, RD .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (11) :1437-1438
[6]  
DOHLEN TW, 1989, AM J CARDIOL, V64, P498
[7]   IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS - CLINICAL ANALYSIS OF 126 PATIENTS WITH EMPHASIS ON NATURAL HISTORY [J].
FRANK, S ;
BRAUNWALD, E .
CIRCULATION, 1968, 37 (05) :759-+
[8]  
GILL CC, 1982, J THORAC CARDIOV SUR, V84, P856
[9]  
GOODWIN JF, 1970, LANCET, V1, P731
[10]   COEXISTENT IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS AND CORONARY ARTERIAL DISEASE [J].
GULOTTA, SJ ;
HAMBY, RI ;
ARONSON, AL ;
EWING, K .
CIRCULATION, 1972, 46 (05) :890-&